{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:49:28Z","timestamp":1793170168490,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12325-019-00964-z","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:15:39Z","timestamp":1558084539000},"page":"1672-1683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Daniel","family":"Aletaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Skup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Zueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishvas","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"964_CR1","unstructured":"Martin L. Autoimmune disorders: causes 2015 (updated May 21, 2017). \n                    https:\/\/medlineplus.gov\/ency\/article\/000816.htm\n                    \n                  . Accessed 2 Apr 2019."},{"issue":"978","key":"964_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","volume":"83","author":"A Kuek","year":"2007","unstructured":"Kuek A, Hazleman BL, Ostor AJ. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J. 2007;83(978):251\u201360.","journal-title":"Postgrad Med J"},{"issue":"5","key":"964_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1185\/030079906X104641","volume":"22","author":"D Robinson Jr","year":"2006","unstructured":"Robinson D Jr, Hackett M, Wong J, Kimball AB, Cohen R, Bala M. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr Med Res Opin. 2006;22(5):989\u20131000.","journal-title":"Curr Med Res Opin"},{"key":"964_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1741-7015-11-73","volume":"11","author":"J Cardenas-Roldan","year":"2013","unstructured":"Cardenas-Roldan J, Rojas-Villarraga A, Anaya JM. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med. 2013;11:73.","journal-title":"BMC Med"},{"issue":"6","key":"964_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/aje\/kwn408","volume":"169","author":"EC Somers","year":"2009","unstructured":"Somers EC, Thomas SL, Smeeth L, Hall AJ. Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol. 2009;169(6):749\u201355.","journal-title":"Am J Epidemiol"},{"issue":"3\u20134","key":"964_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","volume":"33","author":"GS Cooper","year":"2009","unstructured":"Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3\u20134):197\u2013207.","journal-title":"J Autoimmun"},{"issue":"7","key":"964_CR7","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1572-0241.2007.01215.x","volume":"102","author":"X Weng","year":"2007","unstructured":"Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am J Gastroenterol. 2007;102(7):1429\u201335.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"964_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ibd.20406","volume":"14","author":"R Cohen","year":"2008","unstructured":"Cohen R, Robinson D Jr, Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis. 2008;14(6):738\u201343.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"964_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","volume":"129","author":"CN Bernstein","year":"2005","unstructured":"Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129(3):827\u201336.","journal-title":"Gastroenterology"},{"issue":"7","key":"964_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/annrheumdis-2012-202143","volume":"72","author":"WQ Li","year":"2013","unstructured":"Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn\u2019s disease in US women. Ann Rheum Dis. 2013;72(7):1200\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"964_CR11","first-page":"859","volume":"23","author":"DT Rubin","year":"2017","unstructured":"Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M. Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn\u2019s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis. J Manag Care Spec Pharm. 2017;23(8):859\u201367.","journal-title":"J Manag Care Spec Pharm"},{"issue":"11","key":"964_CR12","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/pds.1824","volume":"18","author":"L Liu","year":"2009","unstructured":"Liu L, Allison JE, Herrinton LJ. Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization. Pharmacoepidemiol Drug Saf. 2009;18(11):1086\u201393.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"964_CR13","unstructured":"Campbell M, Swinscow T. Statistics at square one. New York: Wiley; 2011."},{"issue":"2","key":"964_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1214\/08-STS254","volume":"23","author":"B Hansen","year":"2008","unstructured":"Hansen B, Bowers J. Covariate balance in simple, stratified and clustered comparative studies. Stat Sci. 2008;23(2):219\u201336.","journal-title":"Stat Sci"},{"key":"964_CR15","unstructured":"Bowers J, Fredrickson M, Hansen B. XBALANCE: Stata module to compute standardized differences for stratified comparisons via R. Boston College Department of Economics; 2008."},{"issue":"5","key":"964_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"964_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(1):65\u201373.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"964_CR18","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.ophtha.2016.03.010","volume":"123","author":"X Juanola","year":"2016","unstructured":"Juanola X, Loza Santamar\u00eda E, Cordero-Coma M. Description and prevalence of spondyloarthritis in patients with anterior uveitis. Ophthalmology. 2016;123(8):1632\u20136.","journal-title":"Ophthalmology"},{"issue":"8","key":"964_CR19","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/ard.2006.064543","volume":"66","author":"B Vander Cruyssen","year":"2007","unstructured":"Vander Cruyssen B, Ribbens C, Boonen A, et al. The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis. 2007;66(8):1072\u20137.","journal-title":"Ann Rheum Dis"},{"key":"964_CR20","doi-asserted-by":"crossref","unstructured":"Anaya JM, Castiblanco J, Rojas-Villarraga A, et al. The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allergy Immunol. 2012;43(3):256-64.","DOI":"10.1007\/s12016-012-8317-z"},{"issue":"13","key":"964_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2288-13-32","volume":"6","author":"RI Griffiths","year":"2013","unstructured":"Griffiths RI, O\u2019Malley CD, Herbert RJ, Danese MD. Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease. BMC Med Res Methodol. 2013;6(13):32.","journal-title":"BMC Med Res Methodol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-00964-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T23:19:02Z","timestamp":1589584742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-00964-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-00964-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}